Cellectar to release top-line data from wm pivotal trial during the jp morgan healthcare conference the week of january 8, 2024

Reports preliminary financial results for third quarter 2023 and provides a corporate update conference call scheduled for today at 8:30 am eastern time florham park, n.j., nov. 02, 2023 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced that top-line data from the pivotal trial in waldenstrom's macroglobulinemia (wm) will be released during the jp morgan healthcare conference the week of january 8, 2024.
CLRB Ratings Summary
CLRB Quant Ranking